Trial · NCT02242643
Results by group1,016
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 1,016
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Haemagglutination Inhibition (HI) Antibody Titers Against Each of the 4 Vaccine Influenza Strains | FluLaval™ Quadrivalent Group | H1N1 [N=972,980] | 716 | Subjects | |
| Haemagglutination Inhibition (HI) Antibody Titers Against Each of the 4 Vaccine Influenza Strains | Fluzone® Quadrivalent Group | H1N1 [N=972,980] | 660 | Subjects | |
| Haemagglutination Inhibition (HI) Antibody Titers Against Each of the 4 Vaccine Influenza Strains | FluLaval™ Quadrivalent Group | H3N2 [N=972,980] | 740 | Subjects | |
| Haemagglutination Inhibition (HI) Antibody Titers Against Each of the 4 Vaccine Influenza Strains | Fluzone® Quadrivalent Group | H3N2 [N=972,980] | 680 | Subjects | |
| Haemagglutination Inhibition (HI) Antibody Titers Against Each of the 4 Vaccine Influenza Strains | FluLaval™ Quadrivalent Group | Victoria [N=973,980] | 631 | Subjects | |
| Haemagglutination Inhibition (HI) Antibody Titers Against Each of the 4 Vaccine Influenza Strains | Fluzone® Quadrivalent Group | Victoria [N=973,980] | 475 | Subjects | |
| Haemagglutination Inhibition (HI) Antibody Titers Against Each of the 4 Vaccine Influenza Strains | FluLaval™ Quadrivalent Group | Yamagata [N=974,980] | 833 | Subjects | |
| Haemagglutination Inhibition (HI) Antibody Titers Against Each of the 4 Vaccine Influenza Strains | Fluzone® Quadrivalent Group | Yamagata [N=974,980] | 723 | Subjects | |
| Humoral Immune Response in Terms of Haemagglutination Inhibition (HI) Antibodies by Calculating Serum Antihaemagglutination (HA) Antibody Titers Against the 4 Vaccine Strains. | FluLaval™ Quadrivalent Group | H1N1 | 98.8 | 95% Confidence Interval 90.3 to 108.2 | Titers |
| Humoral Immune Response in Terms of Haemagglutination Inhibition (HI) Antibodies by Calculating Serum Antihaemagglutination (HA) Antibody Titers Against the 4 Vaccine Strains. | Fluzone® Quadrivalent Group | H1N1 | 84.4 | 95% Confidence Interval 76.9 to 92.6 | Titers |
| Humoral Immune Response in Terms of Haemagglutination Inhibition (HI) Antibodies by Calculating Serum Antihaemagglutination (HA) Antibody Titers Against the 4 Vaccine Strains. | FluLaval™ Quadrivalent Group | H3N2 | 97.7 | 95% Confidence Interval 90.3 to 105.7 | Titers |
| Humoral Immune Response in Terms of Haemagglutination Inhibition (HI) Antibodies by Calculating Serum Antihaemagglutination (HA) Antibody Titers Against the 4 Vaccine Strains. | Fluzone® Quadrivalent Group | H3N2 | 84.3 | 95% Confidence Interval 77.6 to 91.6 | Titers |
| Humoral Immune Response in Terms of Haemagglutination Inhibition (HI) Antibodies by Calculating Serum Antihaemagglutination (HA) Antibody Titers Against the 4 Vaccine Strains. | FluLaval™ Quadrivalent Group | Yamagata | 257.5 | 95% Confidence Interval 240.9 to 275.3 | Titers |
| Humoral Immune Response in Terms of Haemagglutination Inhibition (HI) Antibodies by Calculating Serum Antihaemagglutination (HA) Antibody Titers Against the 4 Vaccine Strains. | Fluzone® Quadrivalent Group | Yamagata | 164.2 | 95% Confidence Interval 151.8 to 177.6 | Titers |
| Humoral Immune Response in Terms of Haemagglutination Inhibition (HI) Antibodies by Calculating Serum Antihaemagglutination (HA) Antibody Titers Against the 4 Vaccine Strains. | FluLaval™ Quadrivalent Group | Victoria | 55.1 | 95% Confidence Interval 50.8 to 59.8 | Titers |
| Humoral Immune Response in Terms of Haemagglutination Inhibition (HI) Antibodies by Calculating Serum Antihaemagglutination (HA) Antibody Titers Against the 4 Vaccine Strains. | Fluzone® Quadrivalent Group | Victoria | 33.4 | 95% Confidence Interval 30.6 to 36.4 | Titers |
Haemagglutination Inhibition (HI) Antibody Titers Against Each of the 4 Vaccine Influenza Strains, Overall, by Age Group (6-17 and 18-35 Months of Age) and by Priming Status (Vaccine-primed and Vaccine-unprimed) | FluLaval™ Quadrivalent Group | H1N1, Day 0 | 11.0 | 95% Confidence Interval 10.2 to 12.0 | Titers |
Haemagglutination Inhibition (HI) Antibody Titers Against Each of the 4 Vaccine Influenza Strains, Overall, by Age Group (6-17 and 18-35 Months of Age) and by Priming Status (Vaccine-primed and Vaccine-unprimed) | Fluzone® Quadrivalent Group | H1N1, Day 0 | 11.1 | 95% Confidence Interval 10.2 to 12.0 | Titers |
Haemagglutination Inhibition (HI) Antibody Titers Against Each of the 4 Vaccine Influenza Strains, Overall, by Age Group (6-17 and 18-35 Months of Age) and by Priming Status (Vaccine-primed and Vaccine-unprimed) | FluLaval™ Quadrivalent Group | H1N1, Day 28/Day 56 | 98.8 | 95% Confidence Interval 90.3 to 108.2 | Titers |
Haemagglutination Inhibition (HI) Antibody Titers Against Each of the 4 Vaccine Influenza Strains, Overall, by Age Group (6-17 and 18-35 Months of Age) and by Priming Status (Vaccine-primed and Vaccine-unprimed) | Fluzone® Quadrivalent Group | H1N1, Day 28/Day 56 | 84.4 | 95% Confidence Interval 76.9 to 92.6 | Titers |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02242643/results